These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2654 related items for PubMed ID: 24630337
41. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. Sartipy U, Dahlström U, Fu M, Lund LH. JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451 [Abstract] [Full Text] [Related]
42. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome. Oliva F, Mortara A, Cacciatore G, Chinaglia A, Di Lenarda A, Gorini M, Metra M, Senni M, Maggioni AP, Tavazzi L, IN-HF Outcome Investigators. Eur J Heart Fail; 2012 Nov; 14(11):1208-17. PubMed ID: 22833614 [Abstract] [Full Text] [Related]
43. Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry). Kobayashi Y, Omote K, Nagai T, Kamiya K, Konishi T, Sato T, Kato Y, Komoriyama H, Tsujinaga S, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T. Am J Cardiol; 2020 Mar 01; 125(5):772-776. PubMed ID: 31898963 [Abstract] [Full Text] [Related]
44. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. Tromp J, Khan MA, Klip IT, Meyer S, de Boer RA, Jaarsma T, Hillege H, van Veldhuisen DJ, van der Meer P, Voors AA. J Am Heart Assoc; 2017 Mar 30; 6(4):. PubMed ID: 28360225 [Abstract] [Full Text] [Related]
45. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, Rouleau JL, Granger CB, McMurray JJ. Eur J Heart Fail; 2016 Dec 30; 18(12):1508-1517. PubMed ID: 27427441 [Abstract] [Full Text] [Related]
46. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction. Rusinaru D, Houpe D, Szymanski C, Lévy F, Maréchaux S, Tribouilloy C. Eur J Heart Fail; 2014 Sep 30; 16(9):967-76. PubMed ID: 25111982 [Abstract] [Full Text] [Related]
47. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. Wolsk E, Claggett B, Køber L, Pocock S, Yusuf S, Swedberg K, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD. Eur J Heart Fail; 2018 Mar 30; 20(3):504-510. PubMed ID: 29193462 [Abstract] [Full Text] [Related]
48. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. Agra Bermejo R, Gonzalez Babarro E, López Canoa JN, Varela Román A, Gómez Otero I, Oro Ayude M, Parada Vazquez P, Gómez Rodríguez I, Díaz Castro O, González Juanatey JR. Cardiol J; 2018 Mar 30; 25(3):353-362. PubMed ID: 28980289 [Abstract] [Full Text] [Related]
49. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort. Hoong CW, Lim CP, Gao F, Chen Q, Kawa LB, Ching CK, Sim DK. J Cardiovasc Med (Hagerstown); 2015 Sep 30; 16(9):583-90. PubMed ID: 25022929 [Abstract] [Full Text] [Related]
50. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP, Linssen GC, Smeele FJ, van Drimmelen AA, Schaafsma HJ, Westendorp PH, Rademaker PC, van de Kamp HJ, Hoes AW, Brugts JJ, CHECK-HF Investigators. JACC Heart Fail; 2019 Jan 30; 7(1):13-21. PubMed ID: 30606482 [Abstract] [Full Text] [Related]
53. Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients. Liu DP, Wang F, Zeng XZ, Zhang XC. Chin Med J (Engl); 2012 Aug 30; 125(16):2853-7. PubMed ID: 22932079 [Abstract] [Full Text] [Related]
56. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, Devore AD, Yancy CW, Fonarow GC. J Am Coll Cardiol; 2017 Nov 14; 70(20):2476-2486. PubMed ID: 29141781 [Abstract] [Full Text] [Related]
57. Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction. Casado J, Montero M, Formiga F, Carrera M, Urrutia A, Arévalo JC, Pérez-Calvo JI, RICA Investigators. Eur J Intern Med; 2013 Oct 14; 24(7):677-83. PubMed ID: 23830876 [Abstract] [Full Text] [Related]
58. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Piña I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorghiade M, Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators. Am Heart J; 2010 May 14; 159(5):841-849.e1. PubMed ID: 20435194 [Abstract] [Full Text] [Related]
59. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. Yamaguchi T, Kitai T, Miyamoto T, Kagiyama N, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Yamaguchi J, Iwai T, Hijikata S, Masuda R, Miyazaki R, Hara N, Nagata Y, Nozato T, Matsue Y. Am J Cardiol; 2018 Apr 15; 121(8):969-974. PubMed ID: 29477488 [Abstract] [Full Text] [Related]
60. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Lam PH, Packer M, Gill GS, Wu WC, Levy WC, Zile MR, Brar V, Arundel C, Cheng Y, Singh SN, Allman RM, Fonarow GC, Ahmed A. Am J Med; 2020 Oct 15; 133(10):1187-1194. PubMed ID: 32272101 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]